Formulation and Evaluation of Pulsatile Drug Delivery System of Dexlansoprazole

DOI:

https://doi.org/10.37285/ijpsn.2023.16.5.6

Authors

  • Tushar Agam Shri. D.D Vispute College of Pharmacy and Research Center, Panvel
  • Gangotri Yadav Shri. D.D Vispute College of Pharmacy and Research Center, Panvel.
  • Ashish Jain Shri. D.D Vispute College of Pharmacy and Research Center, Panvel.
  • Pallavi Ware Shri. D.D Vispute College of Pharmacy and Research Center, Panvel.
  • Srushti Kamble Shri. D.D Vispute College of Pharmacy and Research Center, Panvel.

Abstract

Background: A pulsatile drug delivery system is intended to deliver drugs according to the circadian rhythm, or disease cycle. PDDS prepared by pulsincap technology contain a cross-linked hard gelatin capsule filled with the optimized immediate-release tablet, sodium alginate beads. Dexlansoprazole is used to treat the signs and symptoms of gastroesophageal reflux disease (GERD), erosive esophagitis, and stomach ulcers.

Objective: The objective of the research is to develop and analyse a controlled-release pulsatile medication delivery system for the treatment of peptic ulcers that contains dexlansoprazole.

Method: The Pulsincap system consists of a hard gelatin capsule containing an immediate-release tablet prepared by direct compression, sodium alginate beads prepared by the ionotropic gelatin method, and a hydrogel plug made through direct compression. The hydrogel plug was prepared by using various grades of HPMC polymer. The immediate-release tablet was prepared by direct compression.

Result: The results of the present FTIR studies concluded that there was no interaction between dexlansoprazole and the excipient. Based on the evaluation parameter, it was found that the F2 tablet (1:2) ratio and 2% sodium alginate beads showed better results. Polymer HPMC K15M for Hydrogel showed the desired swelling time.

Conclusion: It was concluded that the preparation of a pulsatile drug delivery system for dexlansoprazole through pulsincap technology can give drug release in a pulsed manner that is first immediate release, lag time, and sustain action.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

dexlansoprazole, Pulsatile drug delivery, immediate-release tablet, sodium alginate beads, Peptic ulcer, pulcincap

Published

2023-09-15

How to Cite

1.
Agam T, Yadav G, Jain A, Ware P, Kamble S. Formulation and Evaluation of Pulsatile Drug Delivery System of Dexlansoprazole . Scopus Indexed [Internet]. 2023 Sep. 15 [cited 2024 Feb. 26];16(5):6976-8. Available from: https://ijpsnonline.com/index.php/ijpsn/article/view/3774

Issue

Section

Research Articles

References

Patel JD, Aneja K, Majumdar SH. Pulsatile Drug Delivery System- An “User-Friendly” Dosage Form. JPRHC. 2011;2(2):204–15.

Umamaheshwari RB, Jain NK. Controlled & novel drug delivery system. 2005;419–54.

Brahmankar MD, Jaiswal BS. control release medication. In: Biopharmaceutical & pharmacokinetics- A treatise. New Delhi, India: Vallabhprakashan; 1995. p. 397–429.

Modi MP, Mathew ST. Pulsatile A Tool For Circadian Rhythm: A Review. Pulsatile A Tool For Circadian Rhythm: A Review Journal of Drug Delivery and Therapeutics. 2012;2(1).

Grover C, Bhatt G, Kothiyal P. A comprehensive review of pulsatile drug delivery system. The pharma innovation. 2012;1.

Natarajan R, Komala G, Ramcy TR, Swathi P, Mohan S. Dissolution enhancement of aceclofenac solid dispersion prepared with hydrophilic carriers by a solvent evaporation method. IJRPC. 2014;4(1):83–90.

Remington .The Science and Practice of Pharmacy. 19th Edition Vol I. 1995.

Pasham S, Venkatesh DP, Sujit N. Pulsatile drug delivery system: An overview. A formulation approach for the treatment of diseases. Int J Curr Pharm Res. 2020;14:16–21.

Yadav D, Survase S, Kumar N. Dual coating of swellable and rupturable polymers on glipizide loaded MCC pellets for pulsatile delivery: formulation design and in vitro evaluation. Int J Pharm [Internet]. 2011;419(1–2):121–30.

Soni V, Singh R, Srinivasan R, Jain SK. Pulsatile insulin delivery through the ocular route. Drug Deliv [Internet]. 1998;5(1):47–51.

Amol JS. Formulation and optimization of floating pulsatile aceclofenac microspheres using response surface methodology. Int Res J Pharm. 2012;3:166–9.

Sinha VR, Bhinge JR, Kumria R, Kumar M. Development of pulsatile systems for targeted drug delivery of celecoxib for prophylaxis of colorectal cancer. Drug Deliv [Internet]. 2006;13(3):221–5.

Jeon JH, Thomas MV, Puleo DA. Bioerrodible devices for intermittent release of simvastatin acid. International Journal of Pharmaceutics. 2007;340(1–2):6–12.

Youan B-BC. Chronopharmaceutical drug delivery systems: Hurdles, hype or hope? Adv Drug Deliv Rev [Internet]. 2010;62(9–10):898–903.

Chickpetty SM, Baswaraj R, Kumar GS. Development of novel combined time and pH-dependent based drug delivery systems for targeting 5- fluorouracil to the colon. Curr Drug Deliv [Internet]. 2011;8(5):566–74.

Kim JE, Cho HJ, Kim DD. Budesonide/cyclodextrin complex loaded lyophilized micro-particles for intranasal application. Drug development and industrial pharmacy. 2014;40:743–8.

Prasanth V, Mitesh P, Modi ST. Pulsatile: a tool for circardian rhythm-a review. Journal of Drug delivery and Therapeutics. 2012;2(1).

Gothoskar AV, Joshi AM, Joshi NH. Pulsatile drug delivery systems: a review. Drug Del Tec. 2004;4:1–1.

Crison JR, Siersma PR, Amidon GL. A novel programmable oral release technology for delivering drugs: human feasibility testing using gamma scintigraphy. Proceed Intern Symp Control Rel Bioact Mater. 1996;23:51–2.

Mc G, Sumitra GM. Modulation of active pharmaceutical material release from a novel ‘tablet in capsule system’ containing an effervescent blend. Journal of controlled release. 2002;79(1–3):157–64.

Reddy KR, Jyothsna MV. Review on pulsatile drug delivery systems. Journal of Pharmaceutical Sciences and Research. 2009;1(4).

British pharmacopeia

Kakade SM, Mannur VS, Ramani KB, Dhada AA, Naval CV, Bhagavat A. Formulation and Evaluation of mouth dissolving tablets of losartan potassium by direct compression techniques. International journal Research pharm Sci. 2010;1(3):290–5.

Gupta M, Patel G, Nimesh S, Madhulika K. Enhancement of dissolution rate of ibuprofen by preparing solid dispersion using different methods. Int J Pharm Pharm Sci. 2011;3(3):204–6.

Vyas J, Jain PJ. Preparation and characterization of solid dispersion of modafinil for improvement of dissolution profile. Int J Pharm and Pharmaceutical Sci. 2012;14(5):348–52.

Natarajan R, Komala G, Ramcy TR, Swathi P, Mohan S. Dissolution enhancement of aceclofenac solid dispersion prepared with hydrophilic carriers by solvent evaporation method. IJRPC. 2014;4(1):83–9.

Yadav M, Srivastava B, Bhalla V, Kalra N, Attri K. Preparation and evaluation of ketoprofen-loaded sodium alginate beads. Asian Pac J Health Sci [Internet]. 2019;6(1):199–205.

Rasel MAT and Hasan M. Formulation and Evaluation of Floating Alginate Beads of Diclofenac Sodium. Dhaka University Journal of Pharmaceutical Sciences 2012;11(1):29–35

Sambasivarao A. Formulation and Evaluation of Immediate Release Tablets of Glimepiride by Using Solid Dispersion Technique Using Gelucires. World Journal of Pharmacy and Pharmaceutical Sciences. 2016;5(5):1659– 78.